Bronchopulmonary dysplasia / chronic lung disease of prematurity
Chronic lung disease of prematurity · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
BPD is chronic lung disease defined by oxygen/respiratory support dependence at 36 weeks postmenstrual age (or 28 days), resulting from immature lungs injured by oxygen, mechanical ventilation and inflammation. Management focuses on prevention, gentle respiratory support, optimising nutrition and growth and minimising further injury.
Red flags
- Rising oxygen requirement or recurrent desaturations suggesting pulmonary hypertension
- Acute deterioration (infection, air leak or airway obstruction)
- Poor weight gain despite adequate intake
- Cyanotic/‘BPD spells’ with agitation
- Signs of right heart strain or cor pulmonale
Assessment
Differential diagnosis
- Evolving/unresolved respiratory distress syndrome
- Recurrent pulmonary infection or aspiration
- Pulmonary hypertension complicating BPD
- Large PDA or other congenital heart disease
- Airway abnormality (tracheobronchomalacia, subglottic stenosis)
- Interstitial lung disease of prematurity
Investigations
- Chest radiograph (hyperinflation, cystic/fibrotic changes)
- Blood gases trending CO2 and oxygenation needs
- Echocardiography to screen for pulmonary hypertension
- Growth and nutritional assessment
- Assessment of oxygen requirement at 36 weeks PMA (physiological challenge where used)
- Consider bronchoscopy/CT for atypical or severe disease
Management
- Prevent BPD: antenatal steroids, surfactant, early CPAP, caffeine and volume-targeted lung-protective ventilation.
- Use the least invasive effective support (CPAP/high-flow over invasive ventilation where possible).
- Target appropriate oxygen saturations (commonly 90–95%) to avoid both hypoxia and hyperoxia.
- Permit mild permissive hypercapnia to allow lower ventilator pressures.
- Optimise nutrition with high calorie intake to support lung growth; monitor growth closely.
- Use fluid restriction and, selectively, diuretics for fluid overload/worsening lung mechanics.
- Consider a short, tapering course of postnatal corticosteroids in ventilator-dependent infants at high BPD risk, after discussing risks/benefits.
- Screen for and manage pulmonary hypertension with echocardiography and specialist input.
- Treat intercurrent infections promptly and ensure immunisations plus RSV prophylaxis where indicated.
- Plan weaning of respiratory support and, if needed, home oxygen with a structured follow-up.
- Involve multidisciplinary team (dietitian, physiotherapy, respiratory, family).
- Arrange long-term respiratory and neurodevelopmental follow-up.
Drugs & doses
Caffeine citrate 20 mg/kg loading then 5–10 mg/kg/day (started early to reduce BPD)
Dexamethasone (DART low-dose regimen) ~0.15 mg/kg/day tapering over ~10 days for ventilator-dependent high-risk infants
Furosemide 1 mg/kg IV or 1–2 mg/kg PO per dose (intermittent) for fluid overload
Chlorothiazide 10–20 mg/kg/dose PO twice daily ± spironolactone 1–1.5 mg/kg/dose twice daily for chronic diuresis
Palivizumab 15 mg/kg IM monthly in RSV season for eligible infants
Disposition
Ongoing neonatal/respiratory care with MDT support; discharge planning with home oxygen and follow-up when stable; tertiary respiratory and pulmonary hypertension review for severe disease.
Complications & pitfalls
- Pulmonary hypertension and cor pulmonale
- Recurrent respiratory infections and hospitalisation
- Growth failure
- Neurodevelopmental impairment
- Systemic corticosteroid side-effects
- Airway malacia and chronic respiratory morbidity
Exam pearls
- Prevention is the best treatment: antenatal steroids, early CPAP, caffeine and gentle ventilation.
- Reserve systemic steroids for the highest-risk ventilator-dependent infants and use low-dose tapering regimens.
- Always screen established BPD for pulmonary hypertension.
- Nutrition drives lung growth – do not under-feed these infants.
- Avoid hyperoxia; set conservative but safe saturation targets.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.